Clinical trials: Virological Breakthrough
Virological Breakthrough, Prognosis
Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy
Background: Taiwan is one of the area with the highest prevalence of chronic hepatitis B (CHB), and many patients die of hepatitis B virus (HBV)-related cirrhosis or liver cancer that have been the leading causes of death in…
- Trial name
- NCT02582333
- Testing
- Observation for clinical and virological changes
- Where
- 4 sites in Taiwan
- Volunteers
- 347 people
- Sponsor
- Taichung Veterans General Hospital
HIV-1
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
This protocol will study the clinical course of HIV-infection among volunteers who have received either a placebo injection or the experimental vaccine combination of ALVAC-HIV and AIDSVAX B/E prior to HIV-1 infection in…
- Trial name
- NCT00337181
- Where
- Thailand
- Volunteers
- 114 people
- Sponsor
- U.S. Army Medical Research and Development Command
Chronic Hepatitis B Virus Treatment
Resistance to Lamivudine in HBV Egyptian Patients
On treatment parameters for Lamivudine resistance in HBV treated Egyptian patients
- Trial name
- NCT01548820
- Where
- Egypt
- Volunteers
- 230 people
- Sponsor
- Ain Shams University